61% overall MMR and 48% MMR achievement by 24 weeks in the 80 mg QD Phase 1b cohort 67% overall MMR and 55% MMR achievement by 24 weeks in all Phase 1b patients who had previously received 1 or 2 ...

– Successful End-of-Phase 2 meeting with FDA agreeing on key elements of the proposed Phase 3 design, including study population, dosing regimen, and treatment duration – – FDA agrees on UMSARS Part I ...

MELBOURNE, Australia and SAN FRANCISCO, June 09, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, trading under the ASX code ATHDA until 12 June; NASDAQ: ATHE) ("Alterity" or "the Company"), ...

The regulator ticks off on key elements of a phase III trial, including study population, endpoint selection, dosing regimen and treatment duration Alterity’s Multiple System Atrophy (MSA) candidate ...

New York, New York and Rockville, Maryland--(Newsfile Corp. - June 8, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, ...

The Marvel Cinematic Universe is “back to phase zero” with the release of Avengers: Doomsday, co-director Joe Russo has said. Speaking at SXSW, attended by The Hollywood Reporter, Russo told fans to ...

National Gear Repair has released a new technical video showcasing the complete rebuild and reassembly of a massive Gloucester industrial gear drive, giving maintenance teams, plant managers, and ...

MADISON (WKOW) — The North Shore Drive path will close between Bedford Street and John Nolen Drive as part of the John Nolen Drive reconstruction project. Path users will be rerouted to the newly ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Alignment Healthcare founder and chief executive officer John Kao is adding the role of ...

The last time I spoke about Artiva Biotherapeutics (ARTV) it was with a Seeking Alpha article entitled "Artiva: Natural Killer Cell Biotech With First Half Of 2025 Lupus Treatment Data." With respect ...